539470-BOM

The stock has been placed in Graded Surveillance Measure (GSM) list GSM - 0.

Shree Ganesh Bio-Tech (India) Ltd.

BSE: 539470

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Biotechnology

0.56+0.0 (+0.00%)

8 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

22.32

P/E (TTM)

59.12

P/B

0.35

P/S (TTM)

4.49

EV/EBITDA

CAPE (5Y)

18.89

ROE (TTM)

0.60

ROCE (TTM)

-1.51

ROA (TTM)

0.59

Avg 3Y ROE

0.68

Earnings 3Y CAGR

-42.93

Sales 3Y CAGR

-56.99

Sales 5Y CAGR

-22.00

Debt/Equity

0.00

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Shree Ganesh Bio-Tech (India) Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 35.71% for 12-month ended 31 Mar 2026 and the growth was 67.02 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.0 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at same valuation levels as industry median P/E

PE TTM of 59.12 indicates that the stock is expensive on a standalone basis. Discount to industry median P/E is modest at -9.3%

What is P/E Ratio?

Median: 65.18

Value 59.12

21.15306.41

Low but stable ROE

The company reported low ROE of 0.6% for 12-month ended 31 Mar 2026 and ROE improved marginally by 15 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of -19.28% for 12-month ended 31 Mar 2026 and operating margin declined by -1468 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -78.35% for 12-month ended 31 Mar 2026 and the growth was 92.62 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 14.27

Value -78.35

-78.3517.09

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Shree Ganesh Bio-Tech (India) Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Shree Ganesh Bio-Tech (India) Ltd. Shareholding Pattern

Quarterly breakdown of Shree Ganesh Bio-Tech (India) Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Indian Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	1.70	1.92	1.92	1.92	2.42	2.42	2.42	2.42	2.42	2.42	2.42	2.17	2.17	1.42	1.42	1.42	1.42	1.42	1.42	1.42	1.42	1.42
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	1.70	1.92	1.92	1.92	2.42	2.42	2.42	2.42	2.42	2.42	2.42	2.17	2.17	1.42	1.42	1.42	1.42	1.42	1.42	1.42	1.42	1.42
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	100.00	100.00	100.00	98.30	98.08	98.08	98.08	97.58	97.58	97.58	97.58	97.58	97.58	97.58	97.83	97.83	98.58	98.58	98.58	98.58	98.58	98.58	98.58	98.58	98.58
Bodies Corporate	9.12	6.87	9.44	8.20	8.22	8.83	8.87	6.71	2.83	6.68	3.30	3.48	3.40	1.24	5.50	1.33	1.02	0.20	0.20	0.20	0.21	0.22	0.23	0.20	0.26
Others (incl. Retail) No. of shareholders	90.88 794	93.13 790	90.56 828	90.10 914	89.86 1,024	89.25 1,132	89.21 1,118	90.87 3,488	94.75 17,290	90.90 40,848	94.28 55,700	94.10 67,219	94.18 69,864	96.34 71,780	92.33 78,064	96.50 1,39,845	97.56 1,76,687	98.38 1,81,162	98.38 1,85,300	98.38 1,92,007	98.37 1,95,403	98.36 1,92,203	98.35 1,89,342	98.38 1,86,114	98.32 1,83,629

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Shree Ganesh Bio-Tech (India) Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Shree Ganesh Bio-Tech (India) Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Bonus1 new shares for 1 existing shares
Ex-date: 27th Apr 2022Announced on: 7th Mar 2022
Stock Split1 : 10
Ex-date: 10th Feb 2022Announced on: 10th Dec 2021
Nominal value change from INR 10 to INR 1.

Company Profile

Overview of Shree Ganesh Bio-Tech (India) Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Shree Ganesh Bio-Tech (India) Limited is an India-based company. The Company is engaged in the business of production, processing and marketing of hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum and various others.

Key personnel

Ms. Namita Acharya

Company Secretary

Mr. Aman PatelD

Whole-time Chairman of the Board

Mr. Kishan Nityanand NaiduD

Chief Financial Officer, Non-Executive Director

Mr. Nimeshkumar Mohanbhai ParmarD

Non-Executive Independent Director

Mr. Sombir SinghD

Non-Executive Independent Director

Ms. Amrutaben Rajanbhai SolankiD

Non-Executive Independent Director

Incorporated on

02 Sep 1982

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

24 Nov 2015

Free Float

39,29,59,060

Website

http://www.shreeganeshbiotech.com/

Phone no.

+913323988213

Address

126,3/2, 75C,Park Street,, 3rd Floor, Kamdhenu Building,, KOLKATA, 700016, India

Frequently Asked Questions

What is the current share price of Shree Ganesh Bio-Tech (India) Ltd.?

The current share price of Shree Ganesh Bio-Tech (India) Ltd. is ₹ 0.56 as of 8 Jul 2026.

What is the market capitalisation of Shree Ganesh Bio-Tech (India) Ltd.?

The market capitalisation of Shree Ganesh Bio-Tech (India) Ltd. stands at ₹ 22.32 Cr.

What is the PE ratio of Shree Ganesh Bio-Tech (India) Ltd.?

The Price-to-Earnings (PE) ratio of Shree Ganesh Bio-Tech (India) Ltd. is 59.12 as of the latest trailing twelve months data.

What is the ROE and ROCE of Shree Ganesh Bio-Tech (India) Ltd.?

Shree Ganesh Bio-Tech (India) Ltd. has a Return on Equity (ROE) of 0.60% and a Return on Capital Employed (ROCE) of -1.51% as per the latest financial reports.

What is the 52-week high and low of Shree Ganesh Bio-Tech (India) Ltd.?

The 52-week high of Shree Ganesh Bio-Tech (India) Ltd. is - and the 52-week low is -.

What is the dividend yield of Shree Ganesh Bio-Tech (India) Ltd.?

The dividend yield of Shree Ganesh Bio-Tech (India) Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Shree Ganesh Bio-Tech (India) Ltd.?

Foreign Institutional Investors (FII) hold 1.42%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 98.32% of Shree Ganesh Bio-Tech (India) Ltd. shares.

What sector does Shree Ganesh Bio-Tech (India) Ltd. belong to?

Shree Ganesh Bio-Tech (India) Ltd. operates in the Healthcare sector.

What is the beta of Shree Ganesh Bio-Tech (India) Ltd.?

The beta of Shree Ganesh Bio-Tech (India) Ltd. is 0.45, indicating its price volatility relative to the broader market. Over the past 1 year, Shree Ganesh Bio-Tech (India) Ltd. has delivered an absolute return of -35.63%.

What is the RSI of Shree Ganesh Bio-Tech (India) Ltd.?

The 14-day Relative Strength Index (RSI) of Shree Ganesh Bio-Tech (India) Ltd. is 36.49, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Shree Ganesh Bio-Tech (India) Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Shree Ganesh Bio-Tech (India) Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile